Premium
Advanced conventional chondrosarcomas: Time to revisit treatments and clinical research for what is not an indolent disease
Author(s) -
Italiano Antoine
Publication year - 2014
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.28842
Subject(s) - medicine , chondrosarcoma , sarcoma , disease , radiation therapy , clinical trial , chemotherapy , anthracycline , oncology , surgery , cancer , pathology , breast cancer
Medical and surgical oncologists involved in the management of patients with sarcoma know well that the management of those with recurrent chondrosarcoma is quite challenging. In light of the currently available data, anthracycline‐based chemotherapy and radiotherapy represent reasonable options for chondrosarcoma patients not eligible to a clinical trial with good performance status and who have unresectable metastatic or locally advanced disease, respectively.